PUBLISHER: Fortune Business Insights Pvt. Ltd. | PRODUCT CODE: 2070447
PUBLISHER: Fortune Business Insights Pvt. Ltd. | PRODUCT CODE: 2070447
Blood Transfusion Diagnostics Market Size, Share, Growth, Global Industry Analysis, Regional Insights and Forecast to 2026-2034
Growth Factors of blood transfusion diagnostics Market
The global blood transfusion diagnostics market size was valued at USD 5.70 billion in 2025 and is projected to grow from USD 6.04 billion in 2026 to USD 8.98 billion by 2034, exhibiting a CAGR of 5.1% during the forecast period. North America dominated the global blood transfusion diagnostics market with a market share of 34.91% in 2025, supported by advanced healthcare infrastructure, stringent blood screening regulations, and widespread adoption of modern diagnostic technologies.
Blood transfusion diagnostics involves a range of laboratory tests performed on donated blood and blood components before transfusion. These tests include blood grouping, compatibility testing, and screening for infectious diseases such as HIV, hepatitis B, hepatitis C, and syphilis. The primary objective is to ensure transfusion safety, reduce adverse reactions, and prevent the transmission of infections between donors and recipients.
Market Overview
The market is experiencing steady growth due to the increasing prevalence of blood-related disorders, rising surgical procedures, and growing demand for safe blood transfusions worldwide. Conditions such as anemia, hemophilia, cancer, chronic kidney disease, and thrombocytopenia require frequent blood transfusions, creating a strong demand for advanced blood screening and diagnostic solutions.
Growing awareness regarding blood safety and the implementation of strict regulatory standards are further encouraging healthcare providers and blood banks to adopt highly accurate diagnostic technologies. The increasing volume of blood donations globally is also contributing to the demand for efficient blood testing systems.
Market Trends
A major trend shaping the blood transfusion diagnostics market is the shift toward automated molecular diagnostic platforms. Laboratories and blood banks are increasingly replacing manual testing procedures with semi-automated and fully automated systems that improve accuracy, reduce turnaround time, and minimize human errors.
Technologies such as DG Gel testing and advanced nucleic acid testing (NAT) platforms are gaining popularity due to their ability to detect transfusion-transmissible infections with greater precision. Automated workflow solutions are helping healthcare institutions enhance laboratory efficiency while ensuring higher testing reliability.
Market Drivers
One of the primary drivers of market growth is the increasing demand for blood and blood components worldwide. Rising cases of chronic diseases and blood disorders have significantly increased the need for blood transfusions. Additionally, the growing number of surgeries, trauma cases, and childbirth-related procedures continues to support market expansion.
According to healthcare organizations, billions of individuals worldwide suffer from conditions such as anemia, creating substantial demand for blood products and diagnostic screening services. Increasing awareness regarding infection prevention and blood safety programs further strengthens the adoption of blood transfusion diagnostics.
Market Restraints
Despite strong growth prospects, the market faces challenges related to the high cost of diagnostic instruments and testing procedures. Advanced blood screening systems require substantial investment in equipment, reagents, and laboratory infrastructure. These costs can be difficult for healthcare facilities in developing countries to manage.
Additionally, limited healthcare infrastructure, inadequate storage facilities, and a shortage of skilled laboratory professionals in emerging economies may restrict the adoption of advanced blood transfusion diagnostic technologies.
Market Opportunities
Significant opportunities exist in low- and middle-income countries where blood screening coverage remains below global standards. Many healthcare systems are investing in modernization programs to improve blood safety and comply with international screening guidelines.
Manufacturers offering affordable analyzers, reliable reagent supply chains, technical training, and laboratory automation solutions are expected to benefit from these expanding opportunities. Growing investments in healthcare infrastructure across emerging markets will further support future growth.
Market Challenges
Although testing technologies have improved significantly, residual risks associated with bacterial contamination of blood components continue to challenge the industry. Even advanced testing methods may not completely eliminate the risk of infections in certain blood products.
As a result, manufacturers and healthcare organizations are under constant pressure to enhance testing sensitivity, develop more sophisticated screening methods, and improve quality control processes. These efforts often increase operational costs and create challenges for market participants.
Segmentation Analysis
Based on product type, the market is segmented into instruments and reagents & kits. The reagents & kits segment dominated the market in 2025 due to recurring demand for screening and blood typing procedures. The instruments segment is expected to grow at a CAGR of 4.3% during the forecast period.
By application, blood screening accounted for the largest market share in 2025 due to the increasing incidence of transfusion-transmissible infections and strict regulatory requirements. The segment is projected to hold a 67.4% market share in 2026. Blood group typing is expected to expand at a CAGR of 4.8% through 2034.
Based on end-user, independent laboratories and blood banks dominated the market in 2025 owing to the high volume of blood testing activities. The segment is expected to account for 60.2% of the market in 2026. Hospital-based laboratories are projected to grow at a CAGR of 4.8% during the forecast period.
Regional Insights
North America led the global market with revenues of USD 1.99 billion in 2025 and continues to maintain its dominant position due to strong blood donation programs and advanced healthcare systems. The U.S. market is expected to reach USD 1.92 billion in 2026.
Europe secured the second-largest market position and is projected to reach USD 1.83 billion in 2026, supported by the availability of advanced serological and nucleic acid testing solutions. Germany is expected to generate USD 0.36 billion, while the U.K. market is projected to reach USD 0.23 billion in 2026.
Asia Pacific represents the third-largest market and is forecast to reach USD 1.49 billion in 2026. China is anticipated to generate USD 0.47 billion, Japan USD 0.30 billion, and India approximately USD 0.09 billion in 2026. Growing awareness regarding blood donation and increasing prevalence of blood disorders are driving regional growth.
Latin America and the Middle East & Africa are expected to witness moderate growth, supported by improving healthcare infrastructure and rising adoption of blood screening technologies.
Competitive Landscape
The blood transfusion diagnostics market is moderately fragmented, with leading players focusing on research and development, automation technologies, and strategic partnerships. Major companies operating in the market include Grifols, S.A., Immucor, Inc., Bio-Rad Laboratories, Inc., QuidelOrtho Corporation, F. Hoffmann-La Roche Ltd, Abbott, and Merck KGaA.
Recent industry developments include the launch of automated nucleic acid testing platforms, strategic laboratory automation partnerships, expansion of reagent manufacturing facilities, and innovative compatibility testing solutions designed to improve transfusion safety and laboratory productivity.
Conclusion
The global blood transfusion diagnostics market is expected to grow from USD 5.70 billion in 2025 to USD 8.98 billion by 2034, driven by increasing demand for safe blood transfusions, rising prevalence of blood-related disorders, and advancements in automated diagnostic technologies. Expanding blood screening programs, healthcare modernization initiatives in emerging economies, and continuous innovation in molecular testing platforms will continue to support long-term market growth throughout the forecast period.
Growth Rate CAGR of 5.1% from 2026-2034
Segmentation By Product
- Instruments
- Kits & Reagents
By Application
- Blood Screening
- Blood Group Typing
By End-user
- Hospital-based Laboratories
- Independent Laboratories & Blood Banks
By Geography
- North America (By Product, Application, End-user, and Country)
- U.S. (By Application)
- Canada (By Application)
- Europe (By Product, Application, End-user, and Country/ Sub-region)
- U.K. (By Application)
- Germany (By Application)
- France (By Application)
- Italy (By Application)
- Spain (By Application)
- Scandinavia (By Application)
- Rest of Europe (By Application)
- Asia Pacific (By Product, Application, End-user, and Country/ Sub-region)
- China (By Application)
- Japan (By Application)
- India (By Application)
- Australia (By Application)
- Southeast Asia (By Application)
- Rest of Asia Pacific (By Application)
- Latin America (By Product, Application, End-user, and Country/ Sub-region)
- Brazil (By Application)
- Mexico (By Application)
- Rest of Latin America (By Application)
- Middle East & Africa (By Product, Application, End-user, and Country/ Sub-region)
- GCC (By Application)
- South Africa (By Application)
- Rest of the Middle East & Africa (By Application)
Table of Content
1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
2. Executive Summary
3. Market Dynamics
- 3.1. Market Drivers
- 3.2. Market Restraints
- 3.3. Market Opportunities
- 3.4. Market Trends
4. Key Insights
- 4.1. Blood Donations Statistics, By Key Countries, 2025
- 4.2. Prevalence of Key Bleeding Disorders, Key Regions/ Country, 2025
- 4.3. Blood Group Distribution Among Blood Donors in China
- 4.4. Distribution of Blood Group Type Among the Indian & the U.S. Population
- 4.5. Blood Transfusion Statistics, 2025
- 4.6. Key Industry Developments- Mergers, Acquisitions, Partnerships, etc.
5. Global Blood Transfusion Diagnostics Market Analysis, Insights and Forecast, 2021-2034
- 5.1. Market Analysis, Insights and Forecast - By Product
- 5.1.1. Instruments
- 5.1.2. Reagents & Kits
- 5.2. Market Analysis, Insights and Forecast - By Application
- 5.2.1. Blood Screening
- 5.2.2. Blood Group Typing
- 5.3. Market Analysis, Insights and Forecast - By End-user
- 5.3.1. Hospital-based Laboratories
- 5.3.2. Independent Laboratories & Blood Banks
- 5.4. Market Analysis, Insights and Forecast - By Region
- 5.4.1. North America
- 5.4.2. Europe
- 5.4.3. Asia Pacific
- 5.4.4. Latin America
- 5.4.5. Middle East & Africa
6. North America Blood Transfusion Diagnostics Market Analysis, Insights and Forecast, 2021-2034
- 6.1. Market Analysis, Insights and Forecast - By Product
- 6.1.1. Instruments
- 6.1.2. Reagents & Kits
- 6.2. Market Analysis, Insights and Forecast - By Application
- 6.2.1. Blood Screening
- 6.2.2. Blood Group Typing
- 6.3. Market Analysis, Insights and Forecast - By End-user
- 6.3.1. Hospital-based Laboratories
- 6.3.2. Independent Laboratories & Blood Banks
- 6.4. Market Analysis, Insights and Forecast - By Country
- 6.4.1. U.S.
- 6.4.1.1. By Application
- 6.4.2. Canada
- 6.4.2.1. By Application
- 6.4.1. U.S.
7. Europe Blood Transfusion Diagnostics Market Analysis, Insights and Forecast, 2021-2034
- 7.1. Market Analysis, Insights and Forecast - By Product
- 7.1.1. Instruments
- 7.1.2. Reagents & Kits
- 7.2. Market Analysis, Insights and Forecast - By Application
- 7.2.1. Blood Screening
- 7.2.2. Blood Group Typing
- 7.3. Market Analysis, Insights and Forecast - By End-user
- 7.3.1. Hospital-based Laboratories
- 7.3.2. Independent Laboratories & Blood Banks
- 7.4. Market Analysis, Insights and Forecast - By Country/ Sub-region
- 7.4.1. U.K.
- 7.4.1.1. By Application
- 7.4.2. Germany
- 7.4.2.1. By Application
- 7.4.3. France
- 7.4.3.1. By Application
- 7.4.4. Spain
- 7.4.4.1. By Application
- 7.4.5. Italy
- 7.4.5.1. By Application
- 7.4.6. Scandinavia
- 7.4.6.1. By Application
- 7.4.7. Rest of Europe
- 7.4.7.1. By Application
- 7.4.1. U.K.
8. Asia Pacific Blood Transfusion Diagnostics Market Analysis, Insights and Forecast, 2021-2034
- 8.1. Market Analysis, Insights and Forecast - By Product
- 8.1.1. Instruments
- 8.1.2. Reagents & Kits
- 8.2. Market Analysis, Insights and Forecast - By Application
- 8.2.1. Blood Screening
- 8.2.2. Blood Group Typing
- 8.3. Market Analysis, Insights and Forecast - By End-user
- 8.3.1. Hospital-based Laboratories
- 8.3.2. Independent Laboratories & Blood Banks
- 8.4. Market Analysis, Insights and Forecast - By Country/ Sub-region
- 8.4.1. Japan
- 8.4.1.1. By Application
- 8.4.2. China
- 8.4.2.1. By Application
- 8.4.3. India
- 8.4.3.1. By Application
- 8.4.4. Australia
- 8.4.4.1. By Application
- 8.4.5. Southeast Asia
- 8.4.5.1. By Application
- 8.4.6. Rest of Asia Pacific
- 8.4.6.1. By Application
- 8.4.1. Japan
9. Latin America Blood Transfusion Diagnostics Market Analysis, Insights and Forecast, 2021-2034
- 9.1. Market Analysis, Insights and Forecast - By Product
- 9.1.1. Instruments
- 9.1.2. Reagents & Kits
- 9.2. Market Analysis, Insights and Forecast - By Application
- 9.2.1. Blood Screening
- 9.2.2. Blood Group Typing
- 9.3. Market Analysis, Insights and Forecast - By End-user
- 9.3.1. Hospital-based Laboratories
- 9.3.2. Independent Laboratories & Blood Banks
- 9.4. Market Analysis, Insights and Forecast - By Country/ Sub-region
- 9.4.1. Brazil
- 9.4.1.1. By Application
- 9.4.2. Mexico
- 9.4.2.1. By Application
- 9.4.3. Rest of Latin America
- 9.4.3.1. By Application
- 9.4.1. Brazil
10. Middle East & Africa Blood Transfusion Diagnostics Market Analysis, Insights and Forecast, 2021-2034
- 10.1. Market Analysis, Insights and Forecast - By Product
- 10.1.1. Instruments
- 10.1.2. Reagents & Kits
- 10.2. Market Analysis, Insights and Forecast - By Application
- 10.2.1. Blood Screening
- 10.2.2. Blood Group Typing
- 10.3. Market Analysis, Insights and Forecast - By End-user
- 10.3.1. Hospital-based Laboratories
- 10.3.2. Independent Laboratories & Blood Banks
- 10.4. Market Analysis, Insights and Forecast - By Country/ Sub-region
- 10.4.1. GCC Countries
- 10.4.1.1. By Application
- 10.4.2. South Africa
- 10.4.2.1. By Application
- 10.4.3. Rest of Middle East & Africa
- 10.4.3.1. By Application
- 10.4.1. GCC Countries
11. Competitive Analysis
- 11.1. Global Market Share Analysis (2025)
- 11.2. Company Profiles
- 11.2.1. Abbott
- 11.2.2. F. Hoffmann-La Roche AG
- 11.2.3. Grifols, S.A.
- 11.2.4. Immucor, Inc.
- 11.2.5. Bio-Rad Laboratories, Inc.
- 11.2.6. QuidelOrtho Corporation
- 11.2.7. QUOTIENT
- 11.2.8. Merck KGaA
List of Tables
- Figure 1: Global Blood Transfusion Diagnostics Market Revenue Breakdown (USD billion, %) by Region, 2025 & 2034
- Figure 2: Global Blood Transfusion Diagnostics Market Value Share (%), by Product, 2025 & 2034
- Figure 3: Global Blood Transfusion Diagnostics Market Value Share (%), by Application, 2025 & 2034
- Figure 4: Global Blood Transfusion Diagnostics Market Value Share (%), by End-user, 2025 & 2034
- Figure 5: Global Blood Transfusion Diagnostics Market Value (USD billion), by Region, 2025 & 2034
- Figure 6: North America Blood Transfusion Diagnostics Market Value (USD billion), by Product, 2025 & 2034
- Figure 7: North America Blood Transfusion Diagnostics Market Value Share (%), by Product, 2025
- Figure 8: North America Blood Transfusion Diagnostics Market Value (USD billion), by Application, 2025 & 2034
- Figure 9: North America Blood Transfusion Diagnostics Market Value Share (%), by Application, 2025
- Figure 10: North America Blood Transfusion Diagnostics Market Value (USD billion), by End-user, 2025 & 2034
- Figure 11: North America Blood Transfusion Diagnostics Market Value Share (%), by End-user, 2025
- Figure 12: North America Blood Transfusion Diagnostics Market Value (USD billion), By Country, 2025 & 2034
- Figure 13: North America Blood Transfusion Diagnostics Market Value Share (%), By Country, 2025
- Figure 14: Europe Blood Transfusion Diagnostics Market Value (USD billion), by Product, 2025 & 2034
- Figure 15: Europe Blood Transfusion Diagnostics Market Value Share (%), by Product, 2025
- Figure 16: Europe Blood Transfusion Diagnostics Market Value (USD billion), by Application, 2025 & 2034
- Figure 17: Europe Blood Transfusion Diagnostics Market Value Share (%), by Application, 2025
- Figure 18: Europe Blood Transfusion Diagnostics Market Value (USD billion), by End-user, 2025 & 2034
- Figure 19: Europe Blood Transfusion Diagnostics Market Value Share (%), by End-user, 2025
- Figure 20: Europe Blood Transfusion Diagnostics Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
- Figure 21: Europe Blood Transfusion Diagnostics Market Value Share (%), By Country/ Sub-region, 2025
- Figure 22: Asia Pacific Blood Transfusion Diagnostics Market Value (USD billion), by Product, 2025 & 2034
- Figure 23: Asia Pacific Blood Transfusion Diagnostics Market Value Share (%), by Product, 2025
- Figure 24: Asia Pacific Blood Transfusion Diagnostics Market Value (USD billion), by Application, 2025 & 2034
- Figure 25: Asia Pacific Blood Transfusion Diagnostics Market Value Share (%), by Application, 2025
- Figure 26: Asia Pacific Blood Transfusion Diagnostics Market Value (USD billion), by End-user, 2025 & 2034
- Figure 27: Asia Pacific Blood Transfusion Diagnostics Market Value Share (%), by End-user, 2025
- Figure 28: Asia Pacific Blood Transfusion Diagnostics Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
- Figure 29: Asia Pacific Blood Transfusion Diagnostics Market Value Share (%), By Country/ Sub-region, 2025
- Figure 30: Latin America Blood Transfusion Diagnostics Market Value (USD billion), by Product, 2025 & 2034
- Figure 31: Latin America Blood Transfusion Diagnostics Market Value Share (%), by Product, 2025
- Figure 32: Latin America Blood Transfusion Diagnostics Market Value (USD billion), by Application, 2025 & 2034
- Figure 33: Latin America Blood Transfusion Diagnostics Market Value Share (%), by Application, 2025
- Figure 34: Latin America Blood Transfusion Diagnostics Market Value (USD billion), by End-user, 2025 & 2034
- Figure 35: Latin America Blood Transfusion Diagnostics Market Value Share (%), by End-user, 2025
- Figure 36: Latin America Blood Transfusion Diagnostics Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
- Figure 37: Latin America Blood Transfusion Diagnostics Market Value Share (%), By Country/ Sub-region, 2025
- Figure 38: Middle East & Africa Blood Transfusion Diagnostics Market Value (USD billion), by Product, 2025 & 2034
- Figure 39: Middle East & Africa Blood Transfusion Diagnostics Market Value Share (%), by Product, 2025
- Figure 40: Middle East & Africa Blood Transfusion Diagnostics Market Value (USD billion), by Application, 2025 & 2034
- Figure 41: Middle East & Africa Blood Transfusion Diagnostics Market Value Share (%), by Application, 2025
- Figure 42: Middle East & Africa Blood Transfusion Diagnostics Market Value (USD billion), by End-user, 2025 & 2034
- Figure 43: Middle East & Africa Blood Transfusion Diagnostics Market Value Share (%), by End-user, 2025
- Figure 44: Middle East & Africa Blood Transfusion Diagnostics Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
- Figure 45: Middle East & Africa Blood Transfusion Diagnostics Market Value Share (%), By Country/ Sub-region, 2025
- Figure 46: Global Blood Transfusion Diagnostics Market Share (%), By Company, 2025
